Chaiyasut, C.; Sivamaruthi, B.S.; Lailerd, N.; Sirilun, S.; Thangaleela, S.; Khongtan, S.; Bharathi, M.; Kesika, P.; Saelee, M.; Choeisoongnern, T.;
et al. Influence of Bifidobacterium breve on the Glycaemic Control, Lipid Profile and Microbiome of Type 2 Diabetic Subjects: A Preliminary Randomized Clinical Trial. Pharmaceuticals 2023, 16, 695.
https://doi.org/10.3390/ph16050695
AMA Style
Chaiyasut C, Sivamaruthi BS, Lailerd N, Sirilun S, Thangaleela S, Khongtan S, Bharathi M, Kesika P, Saelee M, Choeisoongnern T,
et al. Influence of Bifidobacterium breve on the Glycaemic Control, Lipid Profile and Microbiome of Type 2 Diabetic Subjects: A Preliminary Randomized Clinical Trial. Pharmaceuticals. 2023; 16(5):695.
https://doi.org/10.3390/ph16050695
Chicago/Turabian Style
Chaiyasut, Chaiyavat, Bhagavathi Sundaram Sivamaruthi, Narissara Lailerd, Sasithorn Sirilun, Subramanian Thangaleela, Suchanat Khongtan, Muruganantham Bharathi, Periyanaina Kesika, Manee Saelee, Thiwanya Choeisoongnern,
and et al. 2023. "Influence of Bifidobacterium breve on the Glycaemic Control, Lipid Profile and Microbiome of Type 2 Diabetic Subjects: A Preliminary Randomized Clinical Trial" Pharmaceuticals 16, no. 5: 695.
https://doi.org/10.3390/ph16050695
APA Style
Chaiyasut, C., Sivamaruthi, B. S., Lailerd, N., Sirilun, S., Thangaleela, S., Khongtan, S., Bharathi, M., Kesika, P., Saelee, M., Choeisoongnern, T., Fukngoen, P., Peerajan, S., & Sittiprapaporn, P.
(2023). Influence of Bifidobacterium breve on the Glycaemic Control, Lipid Profile and Microbiome of Type 2 Diabetic Subjects: A Preliminary Randomized Clinical Trial. Pharmaceuticals, 16(5), 695.
https://doi.org/10.3390/ph16050695
